Early results have shown the new test gives a high degree of accuracy in diagnosing cancer and pre-cancerous conditions from the blood of patients with melanoma, colon cancer and lung cancer.The test will enable doctors to rule out cancer in patients presenting with certain symptoms, saving time and preventing costly and unnecessary invasive procedures, researchers said.